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Edited by Jesus AvilaAbstract Dysfunction of the microtubule system is emerging as
a contributing factor in a number of neurodegenerative diseases.
Looking for the potential role played by the microtubule cyto-
skeleton in neuron degeneration underlying Parkinsons disease
(PD), we investigate the inﬂuence of the parkinsonism producing
neurotoxin 1-methyl-4-phenylpyridinium (MPP+) on microtu-
bule dynamics. We ﬁnd that it acts as a strong catastrophe pro-
moter causing a decrease of the average length of microtubules
assembled from puriﬁed tubulin. We also ﬁnd that it reduces
the number of microtubules nucleated from puriﬁed centrosomes.
Finally, binding assays demonstrate that the neurotoxin binds
speciﬁcally to tubulin in the microtubule lattice in a close to stoi-
chiometric manner. This paper provides the ﬁrst evidence that
dynamic instability of microtubules is speciﬁcally aﬀected by
MPP+ and suggests that it could play a role in neuronal cell
death underlying PD.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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disease1. Introduction
The molecular pathways implicated in common neurodegen-
erative disorders are gradually being elucidated and several
crucial events including accumulation of aberrant or misfolded
proteins, mitochondrial injury, oxidative and nitrosative stress,
and failure of axonal and dendritic transport are emerging [1].
Focusing on the dysfunction of the neuronal cytoskeleton, evi-
dence is accumulating that a number of neurodegenerative dis-
eases are characterised by typical abnormalities in the
microtubule system [2,3]. However, little is known about cyto-
skeletal rearrangements involved in the onset of Parkinsons
disease (PD). Tubulin is a major components of Lewy bodies,
cytoplasmic inclusions typical of degenerated neurones in PD
[4]. Recent papers on genetic parkinsonism support to the ideaAbbreviations:DIC, diﬀerential interference contrast; MPP+, 1-methyl-
4-phenylpyridinium; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydro-
pyridine; PD, Parkinsons disease
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doi:10.1016/j.febslet.2005.07.058that the microtubular cytoskeleton could be a player in the
neurodegenerative scenario. They suggest that a link between
tau and PD exists [5] and that the stability of axonal microtu-
bules could be directly aﬀected by a-synuclein [6], which is the
ﬁrst mutated protein linked to PD [7]. They also show that par-
kin, which is linked to autosomal recessive juvenile PD [8], is a
novel tubulin-binding protein, as well as a microtubule-associ-
ated protein [9,10].
We addressed the question of cytoskeleton rearrangements
in PD neurodegeneration by using N-methyl-4-phenyl-
1,2,3,6-tetrahydropyridine (MPTP), a neurotoxin that kills
dopamine neurons and induces PD-like symptoms [11]. It
has therefore become an invaluable experimental tool for stud-
ies on sporadic PD [12]. We reported earlier that 1-methyl-4-
phenylpyridinium (MPP+), the toxic metabolite of MPTP,
inﬂuences the state of tubulin polymerisation in PC12 cell line
diﬀerentiated with nerve growth factor that is commonly used
as a model for dopamine neurons [13,14]. The pool of unpoly-
merised tubulin was signiﬁcantly increased and the synthesis
rate was reduced in PC12 cells treated with sublethal concen-
trations of MPP+. This corresponds exactly to the situation
observed in HeLa cells following depletion of the microtu-
bule-associated protein MAP4 [15] that is known to be an
assembly promoting factor. Because microtubule-destabilising
factors are deﬁned as factors that cause a decrease in the total
microtubule polymer mass when added to microtubules, the ef-
fects evoked by MPP+ in PC12 cells could be the result of
microtubule destabilisation. Looking for a direct eﬀect of the
neurotoxin on microtubules, we have undertaken an in vitro
study by using tubulin puriﬁed from bovine brain and showed
that MPP+ inhibits tubulin polymerisation by lowering the ini-
tial rate and the ﬁnal extent of assembly, and increasing the
critical concentration for polymerisation [16]. In the present
study, we have investigated the molecular mechanisms by
which MPP+ inﬂuences microtubule polymerisation dynamics.
We analysed the eﬀect of MPP+ on the dynamic properties of
microtubules assembled from puriﬁed tubulin by time-lapse vi-
deo microscopy, and tested its ability to interact with dimeric
tubulin or microtubules using a binding assay.2. Materials and methods
2.1. Microtubule assembly assay
Calf brain tubulin and rhodamine-labelled tubulin were prepared
according to Hyman et al. [17]. Pure tubulin (20 lM) was added to a
reaction mixture containing 1.8 lM rhodamine-labelled tubulin, 1 llblished by Elsevier B.V. All rights reserved.
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6.8, 1 mM EGTA, and 1 mM MgCl2). Samples were incubated for
15 min at 37 C or at room temperature in the presence of the indicated
concentrations of MPTP or MPP+ (RBI, Natick, MA, USA), and the
assembled asters were ﬁxed with 1 ml of 10% glycerol, 0.25% glutaral-
dehyde, 0.1% Triton X-100 in BRB80 and spun down onto coverslips.
Images acquisition was performed using a Zeiss Axiovert 10 equipped
with an 100x objective and a digital image recording system (Sony SSC
M370CE CCD camera, Power Mac G3 and Scion Image 1.62 soft-
ware). Microtubule lengths were determined using Scion Image.
2.2. Microtubule dynamics analysis
The behaviour of individual microtubules was monitored by video-
enhanced diﬀerential interference contrast (VE-DIC) microscopy [18].
Centrosomes were diluted to 1 · 104/ll in BRB80, injected into a 4 ll
perfusion chamber and left for 5 min on ice. The chamber was washed
with 30 ll BRB80 and microtubule assembly was initiated by perfusion
of 55 lM tubulin in BRB80 containing 1 mM GTP, 1 mM DTT, and
increasing MPP+ concentrations (always 6 ll total volume). Dynamics
were observed for 40 min at 22 C using an Olympus BX51 microscope
equipped with DIC lens (Plan Apo 60x/1.4 numerical aperture) and
video camera (Hamamatsu 2400 newvicon). Images were recorded
every 2 s, enhanced with a Hamamatsu Argus 20 image processor
and stored on a Macintosh using NIH Image software. Microtubules
were measured in every frame to generate the graphs of microtubule
lifetimes. Data analysis was done with a home-made Microsoft Excel
macro to determine the growth rate and the shrinkage rate of microtu-
bules [19]. Catastrophe frequency was calculated by dividing the total
number of events by the duration of growth and pause phases.2.3. Analysis of tubulin binding
We have measured the binding of MPP+ to tubulin dimers by ultra-
ﬁltration and to microtubules by ﬁltration. Tubulin dimers (25 lM)
were incubated at 0 and 37 C for 1 h in BRB80 containing 50 lM
[3H]-MPP+ (0.2 Ci/mmol, Perkin–Elmer, Wellesley, MA, USA). Tubu-
lin-MPP+ complexes were separated from unbound MPP+ by ultraﬁl-Fig. 1. MPP+ aﬀects the length and number of microtubules nucleated fro
tubulin and centrosomes in the absence (control) or in the presence of 40 lM
length in the absence (control) or in the presence of 40 lM MPP+ obtained
length in the presence of increasing concentrations of MPTP and MPP+. Expe
as indicated in the ﬁgure. (D) Quantiﬁcation of the number of microtu
concentrations. Bars indicate S.E.M. \P < 0.05; \\P < 0.001 according to Stutration using Microcon YM-30 ﬁlters (Millipore Co., Bedford, MA,
USA). The radioactivity was measured both in the retenate and in
the ultraﬁltrate. To conﬁrm the presence of tubulin exclusively in the
retenate, equivalent amounts of the retenate and ultraﬁltate were ana-
lysed by 7.5% SDS–PAGE followed by Coomassie staining. Another
set of experiments were performed on prepolymerised and stabilised
microtubules. Here, microtubules (25 lM tubulin dimer), preincubated
with 20 lM taxol for 15 min at 37 C, were mixed with increasing
MPP+ concentrations (5–80 lM), [3H]-MPP+ (70 lCi/sample), 1 mM
GTP, 20 lM taxol, in BRB80 and incubated for 15 min at 37 C.
Microtubules-MPP+ complexes were separated from unbound MPP+
and tubulin dimers by ﬁltration using Ultrafree-MC microporous ﬁl-
ters (0.1 lm size, Millipore Co., Bedford, MA, USA). Aliquots of the
retenate and ultraﬁltrate were subjected to radioactivity measurement
and analysed by 7.5% SDS–PAGE followed by Coomassie staining. In
equilibrium binding experiments speciﬁc [3H]-MPP+ binding was cal-
culated as the diﬀerence between total binding and non-speciﬁc binding
occurring in the presence of an excess concentration of unlabelled
MPP+ (1000 times the concentration of labelled MPP+). To calculate
binding parameters, data were plotted according to the Scatchard
equation.
2.4. Statistical analysis
The data were analysed using SigmaPlot 8.0 program (Systat Soft-
ware Inc., Point Richmond, CA, USA). Diﬀerence between experi-
ments with or without MPTP and MPP+ were evaluated by a
Students t-test for unpaired data with a conﬁdence level of 95%.3. Results
In order to gain insight into the molecular mechanism by
which MPP+ inﬂuences microtubule polymerisation dynamics,
we have undertaken in vitro experiments with pure tubulin and
microtubules. First, we have evaluated the eﬀect of the neuro-m centrosomes in vitro. (A) Microtubule asters nucleated from pure
MPP+. Bar, 10 lm. (B) Histogram of the frequencies of microtubule
from four independent experiments. (C) Quantiﬁcation of microtubule
riments were performed either at room temperature (22 C) or at 37 C
bules polymerised per asters in the presence of increasing MPP+
dents unpaired t-test.
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of MPP+ reduces the average length of microtubules nucleated
from centrosomes after 20 min of incubation at 37 C
(Fig. 1A). We quantiﬁed the length of microtubules of the as-
ters in the presence of increasing concentrations of MPP+ and
found a concentration-dependent decrease of the microtubule
length (Fig. 1B and C). The MT destabilising eﬀect of MPP+
becomes signiﬁcant at concentrations above 4 lM and it is
stronger when tubulin polymerisation occurs at room temper-
ature as compared to 37 C. In agreement with our previous
data showing that MPTP is ineﬀective on tubulin polymerisa-
tion in vitro [16], the length of microtubules appears to be
unmodiﬁed by MPTP up to 4 mM. In addition to a decrease
of the microtubule length, at higher concentrations of MPP+
we also observed a signiﬁcant decrease in the number of micro-
tubule per aster (Fig. 1D). Therefore, we conclude that the
presence of MPP+ can inﬂuence both the average length of
microtubules assembled from puriﬁed tubulin and the number
of microtubules nucleated from puriﬁed centrosomes.
When individual microtubules are observed by light micros-
copy, both in vivo and in vitro, they display alternating phases
of growth and shortening, collectively termed dynamicFig. 2. MPP+ aﬀects microtubule dynamics. (A) Images of microtu-
bules polymerised from centrosomes and tubulin in the absence
(control) or in the presence of increasing MPP+ concentrations and
visualised after an incubation of 15 min at room temperature by DIC
microscopy. Bar, 10 lM. (B) Life-history traces of microtubules
polymerised in control buﬀer or in the presence of 40 lM MPP+.
Each plot displays the length of individual microtubules.instability [20]. Due to this phenomenon, the steady-state
length of an ensemble of microtubules results from the values
of the rates of growth and shortening of the individual micro-
tubules and from the average frequencies with which they con-
vert between growth and shortening phases. To elucidate the
molecular mechanism by which MPP+ aﬀects the steady-state
length of microtubules, we monitored the real time behaviour
of individual microtubules by VE-DICmicroscopy [18]. Brieﬂy,
puriﬁed centrosomes were adsorbed to the surface of a perfu-
sion chamber, and tubulin was perfused into the chamber in
the absence or presence of increasing MPP+ concentrations,
and allowed to polymerise at room temperature. As expected,
the extent of microtubule polymerisation was reduced with
increasing MPP+ concentrations (Fig. 2A). We analysed the
life-history of individual microtubules polymerised in the ab-
sence or in the presence of MPP+ (Fig. 2B). From such plots
of the microtubule length versus time, we determined the values
of all four parameters deﬁning microtubule dynamic instability
(Fig. 3). The most drastic eﬀect of MPP+ was observed on the
frequency of transitions from growth to shrinkage, i.e., on the
catastrophe frequency. It was signiﬁcantly increased for micro-
tubules polymerised in the presence ofMPP+ (Fig. 3A) in a con-
centration-dependent manner. We observed a 2-fold increase
for microtubules polymerised in the presence of 4 lM MPP+
up to a 20-fold increase at 400 lM MPP+. On the contrary,
the rescue frequency (Fig. 3B), the growth rate (Fig. 3C), and
the shrinkage rate (Fig. 3D) were not strongly inﬂuenced by
MPP+. In detail, the rescue frequency was not signiﬁcantly af-
fected by low concentrations of MPP+ and doubled at the high-
est concentration we tested (400 lM). The growth was reduced
by up to a factor of 2 at 400 lM MPP+ (0.6 ± 0.38 lm/min)
with respect to the control (1.42 ± 0.42 lm/min), and the
shrinkage rate was not aﬀected at all. These results show that
MPP+ strongly inﬂuences microtubule dynamics, mostly by
acting as a catastrophe promoter causing the observed decrease
of the average length of microtubules.
Microtubule dynamics can be modulated by the interaction
of regulatory molecules with soluble tubulin or by binding of
regulatory molecules to distinct binding sites at the microtu-
bule surface or end. To learn more about the mechanism of
the MPP+-induced eﬀect on microtubule dynamics, we tested
its ability to bind dimeric tubulin or microtubules. We incu-
bated free tubulin or taxol-stabilised microtubules with [3H]-
MPP+ and separated the bound fraction of MPP+ from the
unbound fraction by ultraﬁltration. We found no radioactivity
associated with free tubulin showing that MPP+ does not
strongly bind to dimeric tubulin (Fig. 4A). Using this assay,
we cannot rule out, however, that MPP+ might bind weakly
to dimeric tubulin. In contrast, a high amount of [3H]-MPP+
was found to be associated to polymerised tubulin showing
that MPP+ strongly binds to microtubules (Fig. 4B). Next,
we investigated whether the binding to microtubules was con-
centration-dependent. Fig. 4C shows the results of equilibrium
binding studies in which the binding shows saturation behav-
iour with increasing concentrations of [3H]-MPP+. Speciﬁc
[3H]-MPP+ binding was calculated as the diﬀerence between
total binding and non-speciﬁc binding occurring in the pres-
ence of an excess concentration of unlabelled MPP+ (1000
times the concentration of labelled MPP+). To calculate bind-
ing parameters, we analysed the data according to Scatchard
(see Section 2). The Scatchard plot for the speciﬁc [3H]-
MPP+ binding was linear (Fig. 4D), indicating the presence
Fig. 3. MPP+ induces microtubule catastrophe. We measured the parameters of microtubule dynamic instability from the movies recordered over
time of microtubule asters nucleated in the presence of increasing concentrations of MPP+. (A) The catastrophe frequency (fcat), (B) the rescue
frequency (fres), (C) the growth rate, and (D) the shrinkage rate were determined by analysing 51 microtubules for control, 31 microtubules for 4 lM
MPP+, 32 microtubules for 40 lM MPP+ and 7 microtubules for 400 lM MPP+. Bars indicate S.E.M.
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(r = 0.96) yields an equilibrium dissociation constant
KD = 46 lM and the number of binding site per molecule of
tubulin n = 0.49. These results indicate that MPP+ speciﬁcally
binds to tubulin in the microtubule lattice close to stoichiom-
etric manner.4. Discussion
The present study provides the ﬁrst evidence that the parkin-
sonism-producing neurotoxin MPP+ speciﬁcally aﬀects micro-
tubule dynamics in vitro. Microtubules are dynamic polymers
that can transit stochastically between growing and shrinking
states, a behaviour known as dynamic instability [20]. We
show that MPP+ reduces the average length and the number
of microtubules nucleated from centrosomes. It does so by act-
ing as a catastrophe promoting factor, i.e., by increasing the
frequency of transitions from microtubule growth to shrink-
age. We ﬁnally show that MPP+ binds speciﬁcally to tubulin
in the microtubule lattice in a close to stoichiometric manner.
It is interesting to note that the concentrations of MPP+ induc-
ing such a strong eﬀect on microtubule dynamics in vitro are
similar to those required to induce neurotoxicity in neuronal
cells expressing dopamine transporter [13,36]. We suggest that
microtubules might be a novel target in MPP+-induced neuro-
degeneration.
The eﬀect of MPP+ on the catastrophe frequency might
partly be a result of the decreased growth rate as previously
described [21]. However, at MPP+ concentrations well above
its KD we ﬁnd that the increase of the catastrophe frequencyis much more pronounced than the decrease of the growth
rate that is still in a range usually not strongly aﬀecting
the catastrophe frequency. Therefore, MPP+ most likely
has a speciﬁc eﬀect on the catastrophe frequency. Compar-
ing MPP+ to microtubule-destabilising proteins (Stathmin/
Op 18, KinI/XKCM1) that regulate microtubule dynamics
by increasing the catastrophe frequency [22,23], we note a
diﬀerence in the apparent mechanism by which MPP+ and
these catastrophe promoting proteins act. Our binding
experiments show that the neurotoxin speciﬁcally binds to
tubulin along the microtubule lattice in a close to stoichiom-
etric manner and suggest that there is one MPP+ binding
site for every two tubulin heterodimers. This means that
MPP+ regulates the dynamics through the interaction with
a large number of distinct tubulin sites on microtubules.
The usual mechanism of action, however, proposed for
microtubule-destabilising proteins or drugs involves either
the sequestration of tubulin dimers to prevent their assembly
or the speciﬁc interaction with microtubule tips [24,25]. The
stoichiometric binding of MPP+ along the microtubule sur-
face appears therefore to represent a mechanism leading to
microtubule destabilisation. This mode of action is reminis-
cent of the action of a kinesin-like protein (XKLP1) that
binds only weakly all along the microtubules, but neverthe-
less alters their dynamic properties, most likely through a
structural change in the microtubule lattice [27] or even of
vinblastine, a known tubulin-targeting alkaloid that binds
to polymerised tubulin [26]. The structural basis for the reg-
ulation of tubulin by vinbastine has only recently been dis-
covered by X-ray analysis of vinblastine bound to tubulin
in a complex with the RB3 showing that it binds at the
Fig. 4. MPP+ binds to microtubules. (A) Tubulin dimers (25 lM) were incubated in the presence of [3H]-MPP+ (50 lM) for 1 h on ice and then
ultraﬁltrated (Section 2). A Coomassie blue-stained gel shows that tubulin was entirely recovered in the retenate (1). The radioactivity was measured
both in the retenate (1) and in the ultraﬁltrate (2), and expressed as percentage of total radioactivity in the assay. (B) Microtubules polymerised from
pure tubulin (25 lM) in the presence 20 lM taxol were incubated for 1 h at 37 C in the presence of [3H]-MPP+ (50 lM) and then ﬁltrated (Section 2).
The Coomassie Blue-stained gel shows that 90% of tubulin was recovered in the retenate (microtubules) and 10% in the ultraﬁltrate (tubulin dimers).
The radioactivity was measured both in the retenate (1) and in the ﬁltrate (2), and expressed as percentage of total radioactivity in the assay. (C)
Binding of [3H]-MPP+ to microtubules. d, total binding; m, non-speciﬁc binding; s, saturable binding, the diﬀerence between the total and non-
speciﬁc values. Bars indicate S.E.M. (D) Scatchard plot of the saturable binding.
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molecular contact in microtubules could be an attractive tar-
get for microtubule perturbing drugs.
A growing body of evidence indicates that the interaction
with and the subsequent dysfunction of the microtubule
cytoskeleton could be common to other toxins known to
cause PD and to proteins mutated in PD. Gearhart et al.
[28] identiﬁed a-tubulin as one of the brain proteins interact-
ing with an environmental toxin analog of MPP+ by phage
display. In addition, rotenone, whose administration leads to
selective degeneration of nigral neurons and parkinsonism
[29], binds tubulin and potently depolymerises microtubules
in vivo and in vitro [30]. Further evidence arises from stud-
ies on mutated genes in parkinsonism. It has been shown
that a-synuclein is associated with microtubules by copuriﬁ-
cation from rat brain and that tubulin initiates and pro-
motes a-synuclein ﬁbril formation under physiological
conditions in vitro suggesting that a-synuclein could func-
tion as a microtubule-associated protein and, consequently,
be implicated in the regulation of microtubule-dependent
neuronal functions [6]. More recent studies have shown that
parkin is a novel tubulin binding protein that enhances the
ubiquitination and degradation of misfolded tubulin [9,10],
as well as a c-tubulin interacting protein [31]. Here, our re-
sults show that MPP+, the toxic metabolite of MPTP, bindsmicrotubules and aﬀects microtubule stability. In conclu-
sions, the notion that tubulin might be an interaction part-
ner for numerous players in neurodegeneration seems to
become a well supported hypothesis.
It has been recently proposed that there is a limited range of
acceptable microtubule dynamic behaviours in neurons, out-
side of which microtubules cannot function normally and the
cells cannot survive [32]. Among the microtubule-dependent
functions axonal transport could be a good candidate to ex-
plain how a cell could die following microtubule dysfunction.
Although the underlying mechanism connecting microtubule
dynamics to axonal transport is unclear, treatment of cells with
taxol at levels causing a modest overstabilisation of microtu-
bules has been shown to compromise axonal transport [33]
as well as the elevation of tau, known for its role in the stabil-
isation of microtubules, causes transport defects [34]. Another
possibility is that the interference with the dynamics of axonal
microtubules could drastically compromise synaptic function-
ality. This would agree with previous data reporting that the
dynamic instability of microtubules at the distal axon may also
contribute to the release of vescicles from the microtubules and
to the insertion of new membranes into the nerve ends [35]. All
these data support the hypothesis that the change of microtu-
bule dynamics as evoked by MPP+ might be a pathogenic
mechanism leading to neuronal cell death.
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